The apparently partially politically motivated attacker claimed to have exfiltrated over 1.2 million records of personal information in the data breach, some of which dates back decades and included ...

Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...

Akeso, Inc. (HKEX: 9926.HK) is excited to announce that the final Overall Survival (OS) analysis results from the HARMONi-A study, a Phase III study evaluating ivonescimab combined with chemotherapy ...

Despite Palantir's performance, the stock remains at risk of a sharp drawdown, depending on what happens at the macroeconomic ...